Brief: Viva Biotech Holdings Announces Acquisition Of Synthesis Med Chem (Hong Kong)
21/09/2020 24:03
Sept 21 (Reuters) - VIVA Biotech Holdings 1873.HK :
* ANNOUNCES ACQUISITION OF ENTIRE EQUITY INTEREST IN
SYNTHESIS MED
CHEM (HONG KONG)
* DEAL FOR ABOUT US$80 MILLION
Source text for Eikon: ID:nHKS5TfxTR
Further company coverage: 1873.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on VIVA Biotech Holdings
See all newsVIVA Biotech H1 profit falls on weaker investment income, FX headwinds
Brief: Viva Biotech Posts FY Net Profit RMB269.3 Million
Brief: Viva Biotech Received Declaration Letter
Brief: Viva Biotech Says Hangzhou Viva Zongchen Agreed To Invest RMB25.0 Million To Fund
Brief: Viva Biotech Passing Of U.S. FDA On-Site Inspection By Langhua Pharmaceutical